J Sagar Associates (JSA) advised New York Stock Exchange-listed DXC Technologies on the India leg of a US$5 billion sale of its US state and local health and human services business to Veritas Capital.
The deal was signed on 10 March and closed on 1 October. Sajai Singh, a partner at JSA who advised on the deal, told India Business Law Journal that it was “an amazing experience to work with teams, literally in every continent, working towards this deadline”.
You must be a
subscribersubscribersubscribersubscriber
to read this content, please
subscribesubscribesubscribesubscribe
today.
For group subscribers, please click here to access.
Interested in group subscription? Please contact us.
你需要登录去解锁本文内容。欢迎注册账号。如果想阅读月刊所有文章，欢迎成为我们的订阅会员成为我们的订阅会员。
